4.7 Article

Functional brain defects in a mouse model of a chromosomal t(1;11) translocation that disrupts DISC1 and confers increased risk of psychiatric illness

Journal

TRANSLATIONAL PSYCHIATRY
Volume 11, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41398-021-01256-3

Keywords

-

Categories

Funding

  1. MRC [MR/J004367/1]
  2. Brain & Behaviour Research Foundation [23306, 27404]
  3. European Union Seventh Framework Programme [607616FP7]
  4. Scottish Funding Council Scottish Senior Fellowship
  5. Chief Scientists Office Senior Clinical fellowship Starter Grant
  6. University of Edinburgh Wellcome Trust [J22734]
  7. Sir Henry Wellcome postdoctoral fellowship [213674/Z/18/Z]
  8. EUREKA/European Union Eurostars [E! 7675]
  9. NWO Gravitation project: A Roadmap from Neurogenetics to Neurobiology [NWO: 024.004.0212]
  10. MRC [MR/N003896/1, MR/K004603/1, MR/J004367/1, MR/N026063/1, MR/N025377/1, UKDRI-4001] Funding Source: UKRI

Ask authors/readers for more resources

The balanced t(1;11) translocation disrupting DISC1 is associated with schizophrenia and affective disorders. Studies on a mutant mouse model, Der1, revealed dysregulation in synaptic function and plasticity, impacting neurotransmission. Furthermore, alterations in pyramidal neurons and interneurons suggest vulnerability to common schizophrenia-associated genetic variants.
A balanced t(1;11) translocation that directly disrupts DISC1 is linked to schizophrenia and affective disorders. We previously showed that a mutant mouse, named Der1, recapitulates the effect of the translocation upon DISC1 expression. Here, RNAseq analysis of Der1 mouse brain tissue found enrichment for dysregulation of the same genes and molecular pathways as in neuron cultures generated previously from human t(1;11) translocation carriers via the induced pluripotent stem cell route. DISC1 disruption therefore apparently accounts for a substantial proportion of the effects of the t(1;11) translocation. RNAseq and pathway analysis of the mutant mouse predicts multiple Der1-induced alterations converging upon synapse function and plasticity. Synaptosome proteomics confirmed that the Der1 mutation impacts synapse composition, and electrophysiology found reduced AMPA:NMDA ratio in hippocampal neurons, indicating changed excitatory signalling. Moreover, hippocampal parvalbumin-positive interneuron density is increased, suggesting that the Der1 mutation affects inhibitory control of neuronal circuits. These phenotypes predict that neurotransmission is impacted at many levels by DISC1 disruption in human t(1;11) translocation carriers. Notably, genes implicated in schizophrenia, depression and bipolar disorder by large-scale genetic studies are enriched among the Der1-dysregulated genes, just as we previously observed for the t(1;11) translocation carrier-derived neurons. Furthermore, RNAseq analysis predicts that the Der1 mutation primarily targets a subset of cell types, pyramidal neurons and interneurons, previously shown to be vulnerable to the effects of common schizophrenia-associated genetic variants. In conclusion, DISC1 disruption by the t(1;11) translocation may contribute to the psychiatric disorders of translocation carriers through commonly affected pathways and processes in neurotransmission.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available